MedPath

Phase II study of chemoradiotherapy using localized irradiation field for T1-3N0M0 esophageal carcinoma.

Phase 2
Conditions
Esophageal carcinoma
Registration Number
JPRN-UMIN000004435
Lead Sponsor
Department of Radiation Oncology, Yamagata University School of Medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
36
Inclusion Criteria

Not provided

Exclusion Criteria

- Multiple or skip lesions - Prior thoracic irradiation or chemotherapy - Prior esophageal EMR - Synchronous malignancies - Uncontrolled severe complications - Possibility of pregnancy

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Overall survival
Secondary Outcome Measures
NameTimeMethod
Recurrence-free survival, Incidence of adverse effects
© Copyright 2025. All Rights Reserved by MedPath